Effect of rectal enema on intrafraction prostate movement during image-guided radiotherapy - Abstract

INTRODUCTION: Rectal volume and movement are major factors that influence prostate location.

The aim of this study was to assess the effect of a rectal enema on intrafraction prostate motion.

METHODS: The data from 12 patients with localised prostate cancer were analysed. Each patient underwent image-guided radiotherapy (RT), receiving a total dose of 70 Gy in 28 fractions. Rectal enemas were administered to all of the patients before each RT fraction. The location of the prostate was determined by implanting three fiducial markers under the guidance of transrectal ultrasound. Each patient underwent preparation for IGRT twice before an RT fraction and in the middle of the fraction. The intrafraction displacement of the prostate was calculated by comparing fiducial marker locations before and in the middle of an RT fraction.

RESULTS: The rectal enemas were well tolerated by patients. The mean intrafraction prostate movement in 336 RT fractions was 1.11 ± 0.77 mm (range 0.08-7.20 mm). Intrafraction motions of 1, 2 and 3 mm were observed in 56.0%, 89.0% and 97.6% of all RT fractions, respectively. The intrafraction movements on supero-inferior and anteroposterior axes were larger than on the right-to-left axes (P < 0.05). The CTV-to-PTV margin necessary to allow for movement, calculated using the van Herk formula (2.5Σ + 0.7σ), was 1.50 mm.

CONCLUSIONS: A daily rectal enema before each RT fraction was tolerable and yielded little intrafraction prostate displacement. We think the use of rectal enemas is a feasible method to reduce prostate movement during RT.

Written by:
Choi Y, Kwak DW, Lee HS, Hur WJ, Cho WY, Sung GT, Kim TH, Kim SD, Yun SG.   Are you the author?
Department of Radiation Oncology, School of Medicine, Dong-A University Hospital, Busan, South Korea.

Reference: J Med Imaging Radiat Oncol. 2014 Sep 17. Epub ahead of print.
doi: 10.1111/1754-9485.12239

PubMed Abstract
PMID: 25229723

UroToday.com Prostate Cancer Section